Fig. 6 | Scientific Reports

Fig. 6

From: A pharmacovigilance study of thromboembolism events associated with vascular endothelial growth factor receptor tyrosine kinase inhibitors based on FAERS database

Fig. 6

Factors influencing the SDR of VEGFR-TKI-related TEEs. (A) The proportion of cases with and without concomitant AEs in VEGFR-TKI-related TEE reports. (B) The number of SOCs containing PTs of concomitant AEs. (C) The number of top 30% concomitant medications of VEGFR-TKI-related TEEs. (D) Subgroup analysis results of VEGFR-TKI-related TEEs.

Back to article page